Skip to main content

Advertisement

Log in

Streptococcal infection and immune response in children with Tourette’s syndrome

Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Streptococcal infection and basal ganglia inflammation are hypothesized to be involved in Tourette’s syndrome (TS). There is a need for effective therapies for managing TS. We studied streptococcal infection and immunity in TS following immunomodulator (pidotimod) therapy.

Methods

Blood samples from 58 patients with TS and 128 age-matched healthy controls enabled measurement of antistreptolysin O (ASO), T cells, natural killer (NK) cells, interleukin-6 (IL-6) and interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α). Forty-four patients with abnormal T cell numbers were divided into two groups and treated with pidotimod granules (pidotimod group, n = 20) or pidotimod plus dopaminergic receptor antagonists (combination group, n = 24). Yale Global Tic Severity Scale (YGTSS) scores and immunologic indices were assessed after treatment.

Results

An ASO >1:200 was found in 22.4 % of children with TS, 7.5 % of controls, and 38.9 % of children with both TS and attention deficit hyperactivity disorder (ADHD) compared to 15.0 % of children with TS alone (P < 0.05). Children with TS showed decreased CD3+ and CD4+ T cells, CD4+/CD8+ ratio, IL-6 and IL-8, increased NKC and TNF-α (P < 0.05) as compared to controls. ASO-positive children with TS had lower CD4+ T cells as compared to ASO-negative children with TS, and lower IL-6 and IL-8 levels as compared to controls (P < 0.05). After 8 weeks of pidotimod treatment, IL-8 was increased compared to either tiapride hydrochloride or haloperidol and pidotimod (P < 0.05).

Conclusions

Streptococcal infection in TS patients is associated with immune and cytokine dysfunction, which can be potentially managed with immunomodulator therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bitsko RH, Holbrook JR, Visser SN, Mink JW, Zinner SH, Ghandour RM, Blumberg SJ (2014) A national profile of Tourette syndrome, 2011–2012. J Dev Behav Pediatr 35:317–322

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ali F, Morrison KE, Cavanna AE (2013) The complex genetics of Gilles de la Tourette syndrome: implications for clinical practice. Neuropsychiatry 3:321–330

    Article  Google Scholar 

  3. Bloch M, State M, Pittenger C (2011) Recent advances in Tourette syndrome. Curr Opin Neurol 24:119–125

    Article  PubMed Central  PubMed  Google Scholar 

  4. Egan CA, Marakovitz SE, O’Rourke JA, Osiecki L, Illmann C, Barton L, McLaughlin E, Proujansky R, Royal J, Cowley H, Rangel-Lugo M, Pauls DL, Scharf JM, Mathews CA (2012) Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies. Am J Med Genet B Neuropsychiatr Genet 159B:987–996

    Article  PubMed  Google Scholar 

  5. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM (2003) Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74:602–607

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Kansy JW, Katsovich L, McIver KS, Pick J, Zabriskie JB, Lombroso PJ, Leckman JF, Bibb JA (2006) Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 181:165–176

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Madhusudan N, Cavanna AE (2013) The role of immune dysfunction in the development of tics and susceptibility to infections in Tourette syndrome: a systematic review. Basal Ganglia 3:77–84

    Article  Google Scholar 

  8. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity 39:21–29

    Article  CAS  PubMed  Google Scholar 

  9. Hoekstra PJ, Dietrich A, Edwards MJ, Elamin I, Martino D (2013) Environmental factors in Tourette syndrome. Neurosci Biobehav Rev 37:1040–1049

    Article  PubMed  Google Scholar 

  10. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Dow S, Zamkoff J, Dubbert BK, Lougee L (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. AJ Psychiatry 155:264–271

    CAS  Google Scholar 

  11. Pavone P, Parano E, Rizzo R, Trifiletti RR (2006) Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol 21:727–736

    Article  PubMed  Google Scholar 

  12. Murphy TK, Kurlan R, Leckman J (2010) The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 20:317–331

    Article  PubMed Central  PubMed  Google Scholar 

  13. Kawikova I, Leckman JF, Kronig H, Katsovich L, Bessen DE, Ghebremichael M, Bothwell AL (2007) Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61:273–278

    Article  CAS  PubMed  Google Scholar 

  14. Rizzo R, Gulisano M, Pavone P, Fogliani F, Robertson MM (2006) Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 21:747–753

    Article  PubMed  Google Scholar 

  15. Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E, Rizzo R (2011) The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol 53:951–957

    Article  PubMed  Google Scholar 

  16. Morris CM, Pardo-Villamizar C, Gause CD, Singer HS (2009) Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 276:45–48

    Article  CAS  PubMed  Google Scholar 

  17. Yeh CB, Wu CH, Tsung HC, Chen CW, Shyu JF, Leckman JF (2006) Antineural antibody in patients with Tourette’s syndrome and their family members. J Biomed Sci 13:101–112

    Article  CAS  PubMed  Google Scholar 

  18. Morer A, Vinas O, Lazaro L, Bosch J, Toro J, Castro J (2005) D8/17 monoclonal antibody: an unclear neuropsychiatric marker. Behav Neurol 16:1–8

    Article  PubMed  Google Scholar 

  19. Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC, Arman A, Yazgan Y, Fujii T, Paul S (2001) Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders. Biol Psychiatry 50:566–577

    Article  CAS  PubMed  Google Scholar 

  20. Loiselle CR, Wendlandt JT, Rohde CA, Singer HS (2003) Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol 28:119–125

    Article  PubMed  Google Scholar 

  21. Brilot F, Merheb V, Ding A, Murphy T, Dale RC (2011) Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 76:1508–1513

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Murphy TK, Goodman WK, Fudge MW, Williams RC Jr, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB (1997) B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette’s syndrome? AJ Psychiatry 154:402–407

    Article  CAS  Google Scholar 

  23. Dale RC (2005) Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol 47:785–791

    Article  PubMed  Google Scholar 

  24. Singer HS, Hong JJ, Yoon DY, Williams PN (2005) Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65:1701–1707

    Article  CAS  PubMed  Google Scholar 

  25. Weisz JL, McMahon WM, Moore JC, Augustine NH, Bohnsack JF, Bale JF, Johnson MB, Morgan JF, Jensen J, Tani LY, Veasy LG, Hill HR (2004) D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette’s disorder. Clin Diagn Lab Immunol 11:330–336

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Yiyan R, Erzhen L, Chian C (2007) Monitor and analysis of streptococcal infection and immune function in children with Tourette syndrome. Chin J Pract Pediatr 22:183–186

    Google Scholar 

  27. Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (2008) Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression. Arch Pharm Res 31:1153–1159

    Article  CAS  PubMed  Google Scholar 

  28. Frances A, Mack AH, Ross R, First MB (2000) The DSM-IV classification and psychopharmacology. http://www.acnp.org/G4/GN401000082/CH081.html. Accessed 1 May 2012

  29. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989) The Yale global Tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566–573

    Article  CAS  PubMed  Google Scholar 

  30. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914–920

    Article  CAS  PubMed  Google Scholar 

  31. Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G (2009) Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens. PLoS One 4:e6332

    Article  PubMed Central  PubMed  Google Scholar 

  32. Cardona F, Orefici G (2001) Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 138:71–75

    Article  CAS  PubMed  Google Scholar 

  33. Müller N, Riedel M, Straube A, Günther W, Wilske B (2000) Increased anti-streptococcal antibodies in patients with Tourette’s syndrome. Psychiatry Res 94:43–49

    Article  PubMed  Google Scholar 

  34. Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry 57:667–673

    Article  CAS  PubMed  Google Scholar 

  35. Gold R, Linker RA, Chan A (2007) Termination of inflammation in the nervous system. Rev Neurol (Paris) 163:672–676

    Article  CAS  Google Scholar 

  36. Wang Y, Tang X, Yu B, Gu Y, Yuan Y, Yao D, Ding F, Gu X (2012) Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS One 7:e43436

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92:9328–9332

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Pickering M, Cumiskey D, O’Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663–670

    Article  CAS  PubMed  Google Scholar 

  39. Mukhatyar V, Pai B, Clements I, Srinivasan A, Huber R, Mehta A, Mukhopadaya S, Rudra S, Patel G, Karumbaiah L, Bellamkonda R (2014) Molecular sequelae of topographically guided peripheral nerve repair. Ann Biomed Eng 42:1436–1455

    Article  PubMed  Google Scholar 

  40. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483–490

    Article  CAS  PubMed  Google Scholar 

  41. Parrado A, Canellada A, Gentile T, Rey-Roldán E (2012) Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes. Neuroimmunomodulation 19:359–366

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grant from program of the Capital Applied Research with Clinical Characteristics (D101100050010040). We are grateful to all patients in the Capital Institute of Pediatrics neurological department. We would like to acknowledge assistance from all staff of the neurology department of the Capital Institute of Pediatrics. We thank all participants and their family members for their cooperation in providing both clinical information and samples for the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erzhen Li.

Additional information

Erzhen Li and Yiyan Ruan contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, E., Ruan, Y., Chen, Q. et al. Streptococcal infection and immune response in children with Tourette’s syndrome. Childs Nerv Syst 31, 1157–1163 (2015). https://doi.org/10.1007/s00381-015-2692-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-015-2692-8

Keywords

Navigation